Literature DB >> 9435561

Translocation of verotoxin-1 across T84 monolayers: mechanism of bacterial toxin penetration of epithelium.

D J Philpott1, C A Ackerley, A J Kiliaan, M A Karmali, M H Perdue, P M Sherman.   

Abstract

Verotoxin-producing Escherichia coli (VTEC) are pathogenic bacteria associated with diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome. Verotoxins (VTs) elaborated by these organisms produce cytopathic effects on a restricted number of cell types, including endothelial cells lining the microvasculature of the bowel and the kidney. Because human intestinal epithelial cells lack the globotriaosylceramide receptor for VT binding, it is unclear how the toxin moves across the intestinal mucosa to the systemic circulation. The aims of this study were to determine the effects of VT-1 on intestinal epithelial cell function and to characterize VT-1 translocation across monolayers of T84 cells, an intestinal epithelial cell line. VT-1 at concentrations up to 1 microgram/ml had no effect on the barrier function of T84 monolayers as assessed by measuring transmonolayer electrical resistance (102 +/- 8% of control monolayers). In contrast, both VT-positive and VT-negative VTEC bacterial strains lowered T84 transmonolayer resistance (45 +/- 7 and 38 +/- 6% of controls, respectively). Comparable amounts of toxin moved across monolayers of T84 cells, exhibiting high-resistance values, as monolayers with VTEC-induced decreases in barrier function, suggesting a transcellular mode of transport. Translocation of VT-1 across T84 monolayers paralleled the movement of a comparably sized protein, horseradish peroxidase. Immunoelectron microscopy confirmed transcellular transport of VT-1, since the toxin was observed within endosomes and associated with specific intracellular targets, including the Golgi network and endoplasmic reticulum. These data present a mode of VT-1 uptake by toxin-insensitive cells and suggest a general mechanism by which bacterial toxins lacking specific intestinal receptors can penetrate the intestinal epithelial barrier.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9435561     DOI: 10.1152/ajpgi.1997.273.6.G1349

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  27 in total

1.  Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells.

Authors:  B P Hurley; M Jacewicz; C M Thorpe; L L Lincicome; A J King; G T Keusch; D W Acheson
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

2.  Intestinal Shiga toxin-producing Escherichia coli bacteria mitigate bovine leukemia virus infection in experimentally infected sheep.

Authors:  Witold A Ferens; Rowland Cobbold; Carolyn J Hovde
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Enterohemorrhagic Escherichia coli infection stimulates Shiga toxin 1 macropinocytosis and transcytosis across intestinal epithelial cells.

Authors:  Valeriy Lukyanenko; Irina Malyukova; Ann Hubbard; Michael Delannoy; Edgar Boedeker; Chengru Zhu; Liudmila Cebotaru; Olga Kovbasnjuk
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-10       Impact factor: 4.249

4.  Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharides.

Authors:  Lisa M Harrison; Christel van den Hoogen; Wilhelmina C E van Haaften; Vernon L Tesh
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  Latrunculin B facilitates Shiga toxin 1 transcellular transcytosis across T84 intestinal epithelial cells.

Authors:  Irina Maluykova; Oksana Gutsal; Marina Laiko; Anne Kane; Mark Donowitz; Olga Kovbasnjuk
Journal:  Biochim Biophys Acta       Date:  2008-02-20

Review 6.  Induction of apoptosis by Shiga toxins.

Authors:  Vernon L Tesh
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

7.  Shiga toxin-producing Escherichia coli can impair T84 cell structure and function without inducing attaching/effacing lesions.

Authors:  Z Li; E Elliott; J Payne; J Isaacs; P Gunning; E V O'loughlin
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 8.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

9.  Essential role for verotoxin in sustained stress-activated protein kinase and nuclear factor kappa B signaling, stimulated by Escherichia coli O157:H7 in Vero cells.

Authors:  Pamela Cameron; Deborah Bingham; Andrew Paul; Martin Pavelka; Scott Cameron; Dino Rotondo; Robin Plevin
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

Review 10.  HUS and TTP in Children.

Authors:  Howard Trachtman
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.